Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year clinical outcomes (RECONFIRM-2)-Reference-Cited by-同舟云学术

Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year clinical outcomes (RECONFIRM-2)

Published:2008-04 Issue:2 Volume:18 Page:146-152
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Tanaka Yoshiya,Takeuchi Tsutomu,Inoue Eisuke,Saito Kazuyoshi,Sekiguchi Naoya,Sato Eri,Nawata Masao,Kameda Hideto,Iwata Shigeru,Amano Kouichi,Yamanaka Hisashi

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

http://www.tandfonline.com/doi/pdf/10.3109/s10165-008-0026-3

Reference15 articles.

1. Evolving concepts of rheumatoid arthritis

2. Efficacy and safety of the anti-TNF biologic agents

3. Guidelines for the management of rheumatoid arthritis: 2002 Update

4. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can we predict the risk factors for switching due to ineffectiveness in the first year of therapy with bDMARD in patients with rheumatoid arthritis?;Reumatología Clínica;2024-08

2. Can we predict the risk factors for switching due to ineffectiveness in the first year of therapy with bDMARD in patients with rheumatoid arthritis?;Reumatología Clínica (English Edition);2024-08

3. Are There Sex-Related Differences in the Effectiveness of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients?;Journal of Clinical Medicine;2024-04-18

4. Commentary on Cohen et al.: Role of Clinical Factors in Precision Medicine Test to Predict Nonresponse to TNFi Therapies in Rheumatoid Arthritis;Rheumatology and Therapy;2022-11-27

5. Real-world safety and efficacy of CT-P13, an infliximab biosimilar, in Japanese rheumatoid arthritis patients naïve to or switched from biologics;Modern Rheumatology;2021-09-10